Latest Governance News

Page 329 of 521
Iluka Resources has met its full-year zircon-in-concentrate production guidance by mid-2025 while progressing key projects like Balranald and Eneabba amid ongoing global trade uncertainties.
Maxwell Dee
Maxwell Dee
23 July 2025
Vulcan Energy has won up to €104 million in grants from German federal and state governments to advance its sustainable lithium production project, bolstering Europe’s electric vehicle battery supply chain.
Maxwell Dee
Maxwell Dee
23 July 2025
Hutchison Telecommunications (Australia) Limited has been suspended from ASX trading following compulsory acquisition notices issued by its Amsterdam-based parent company.
Sophie Babbage
Sophie Babbage
22 July 2025
Bod Science Limited reports a positive cash flow quarter driven by customer receipts, an R&D tax incentive, and proceeds from intellectual property sales, while navigating its Deed of Company Arrangement.
Ada Torres
Ada Torres
22 July 2025
Nico Resources Limited reported steady progress on its Wingellina nickel-cobalt project despite challenging market conditions, completing a $1.1 million share placement and advancing metallurgical and drilling programs.
Maxwell Dee
Maxwell Dee
22 July 2025
Prodigy Gold NL has lodged a replacement Appendix 3Y to amend the reported securities held by Managing Director Mark Edwards following his participation in the company’s recent Entitlement Offer.
Maxwell Dee
Maxwell Dee
22 July 2025
Norwest Minerals has reported a substantial 33% increase in its Bulgera Gold Project resource to 288,400 ounces and secured $4.85 million to advance exploration, including a new drilling campaign targeting deeper gold zones.
Maxwell Dee
Maxwell Dee
22 July 2025
Inhalerx Limited has drawn $247,000 from a $38.5 million funding facility to advance clinical trials for its IRX-211 and IRX-616a drug candidates, reporting positive operating cash flow for the quarter ending June 2025.
Ada Torres
Ada Torres
22 July 2025
InhaleRx Limited has secured key ethics approvals and initiated manufacturing for its inhaled drug candidates targeting breakthrough cancer pain and panic disorder, supported by a $38.5 million funding facility to accelerate development.
Ada Torres
Ada Torres
22 July 2025
ECP Emerging Growth Limited reports steady financial health for its convertible notes, confirming a stable loan-to-value ratio and full compliance with regulatory requirements for Q2 2025.
Claire Turing
Claire Turing
22 July 2025
Global Masters Fund Limited has released its quarterly update confirming stable convertible note conversions and a low loan-to-value ratio, underscoring its solid financial footing as of June 2025.
Claire Turing
Claire Turing
22 July 2025
Flagship Investments Limited has reported steady financial health in its latest quarterly filing, confirming a stable loan-to-value ratio and full compliance with convertible note obligations for Q2 2025.
Claire Turing
Claire Turing
22 July 2025